🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 15 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 07/01/2013 | 40,11 | 40,26 | 39,93 | 40,19 | +0,36% | 0,81% | 12.055.773 |
| 04/01/2013 | 40,52 | 40,55 | 39,90 | 40,05 | -0,85% | 1,60% | 16.169.068 |
| 03/01/2013 | 39,97 | 40,49 | 39,23 | 40,39 | +2,39% | 3,15% | 24.673.483 |
| 02/01/2013 | 39,94 | 39,95 | 39,06 | 39,45 | +0,98% | 2,22% | 16.722.831 |
| 31/12/2012 | 38,44 | 39,09 | 38,19 | 39,06 | +0,74% | 2,36% | 15.004.635 |
| 28/12/2012 | 39,12 | 39,28 | 38,77 | 38,78 | -1,36% | 1,32% | 11.862.731 |
| 27/12/2012 | 39,32 | 39,51 | 38,93 | 39,31 | -0,34% | 1,48% | 11.948.877 |
| 26/12/2012 | 39,55 | 39,68 | 39,33 | 39,45 | -0,19% | 0,87% | 7.471.716 |
| 24/12/2012 | 39,53 | 39,84 | 39,42 | 39,52 | -0,24% | 1,06% | 6.793.870 |
| 21/12/2012 | 40,48 | 40,52 | 39,55 | 39,62 | -1,52% | 2,38% | 30.087.242 |
| 20/12/2012 | 40,51 | 40,82 | 40,08 | 40,23 | -3,44% | 1,84% | 35.263.104 |
| 19/12/2012 | 42,13 | 42,42 | 41,61 | 41,66 | -1,31% | 1,93% | 12.254.369 |
| 18/12/2012 | 41,59 | 42,37 | 41,37 | 42,21 | +1,40% | 2,39% | 14.756.888 |
| 17/12/2012 | 41,63 | 41,83 | 41,52 | 41,63 | +0,21% | 0,76% | 13.917.650 |
| 14/12/2012 | 41,89 | 41,95 | 41,42 | 41,55 | -0,93% | 1,25% | 13.818.928 |
| 13/12/2012 | 42,88 | 42,88 | 41,89 | 41,94 | -2,89% | 2,31% | 14.404.131 |
| 12/12/2012 | 43,14 | 43,41 | 42,96 | 43,19 | +0,15% | 1,04% | 11.790.000 |
| 11/12/2012 | 42,61 | 43,21 | 42,46 | 43,12 | +1,60% | 1,75% | 14.235.508 |
| 10/12/2012 | 42,42 | 42,78 | 42,39 | 42,44 | -0,34% | 0,92% | 9.796.180 |
| 07/12/2012 | 42,49 | 42,60 | 42,14 | 42,59 | +0,27% | 1,08% | 8.247.236 |
| 06/12/2012 | 42,41 | 42,55 | 42,35 | 42,47 | +0,27% | 0,47% | 9.240.216 |
| 05/12/2012 | 42,30 | 42,71 | 42,20 | 42,36 | -0,02% | 1,20% | 12.206.056 |
| 04/12/2012 | 42,35 | 42,73 | 42,35 | 42,37 | -0,09% | 0,90% | 10.476.751 |
| 03/12/2012 | 42,43 | 42,78 | 42,39 | 42,40 | +0,32% | 0,92% | 12.177.865 |
| 30/11/2012 | 42,50 | 42,66 | 42,10 | 42,27 | -0,92% | 1,32% | 15.738.026 |
| 29/11/2012 | 42,89 | 42,89 | 42,44 | 42,66 | +0,25% | 1,05% | 10.018.356 |
| 28/11/2012 | 41,75 | 42,57 | 41,55 | 42,56 | +1,64% | 2,45% | 11.124.310 |
| 27/11/2012 | 42,01 | 42,17 | 41,84 | 41,87 | -0,72% | 0,77% | 9.294.922 |
| 26/11/2012 | 41,98 | 42,30 | 41,91 | 42,18 | -0,18% | 0,93% | 9.831.393 |
| 23/11/2012 | 41,98 | 42,26 | 41,91 | 42,25 | +0,89% | 0,84% | 4.692.734 |